US 7,256,008 B2Granted

Determination of concentration of FK778 by competitive immunoassay

AssigneeAbbott Laboratories

InventorsThomas G. Spring, Elaine M. Brate, Shelley Holets-McCormack, Rajarathnam E. Reddy, Donald D. Johnson, Yon-Yih Chen, You Pan

Life of this patent

Estimating the term…

patentgrep

Loading patent…

Abstract

Methods and kits for measurement of concentration of FK778 in a biological sample by means of an immunoassay, preferably a competitive immunoassay. In one aspect, the method and kit involve the use of (a) an antibody to FK778 conjugated to a label, e.g., an acridinium label, (b) an antibody to FK778 not conjugated to a label, (c) a solid phase containing an antibody to a first hapten, e.g., a fluorescein hapten, and (d) a bihapten comprising a first hapten and FK778 or an analogue of FK778, e.g., a bihapten comprising a fluorescein hapten and a FK778 hapten. In another aspect, the method and kit involve the use of (a) antibody to FK778, (b) a bihapten comprising FK778 or an analogue of FK778 and a first hapten, e.g., a bihapten comprising the fluorescein hapten and the hapten of FK778 or an analogue of FK778, and (c) a pretreatment reagent.

Claims3

Dependent claims

A method for determining the amount of FK778 in a test sample comprising the steps of:

(a) incubating a mixture comprising a test sample suspected of containing FK778, a solid phase coupled to an antibody specific for a first hapten, a bihapten comprising FK778 or an analogue of FK778 and the first hapten, and a reagent mixture comprising an antibody to FK778 conjugated to a label and an antibody to FK778 not conjugated to a label, wherein the ratio of the antibody to FK778 conjugated to a label to the antibody to FK778 not conjugated to a label in the reagent mixture ranges from about 1:135 to about 1:225, to form a detectable complex comprising (i) the antibody to FK778 conjugated to the label, (ii) a bihapten comprising a first hapten and FK778 or an analogue of FK778, and (iii) the solid phase coupled to the antibody specific for the first hapten;
(b) separating the solid phase from the mixture;
(c) measuring the amount of label bound to the solid phase;
and
(d) determining the amount of FK778 in the test sample from the amount of label measured.

2 more elements

Dependencies are inferred from the claim text.